SCHEMBL5768385

SCHEMBL5768385

CCOC(=O)C1(/C(O)=C2/CCN(Cc3ccccc3)C2=O)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
MEN1 O00255 5/20 0.45
KMT2A Q03164 5/20 0.45
ALDH1A1 P00352 3/20 0.45
KDM4E B2RXH2 2/20 0.44
GAA P10253 1/20 0.44
LMNA P02545 2/20 0.44
CASP3 P42574 1/20 0.44
SMN1; SMN2 Q16637 2/20 0.43
POLB P06746 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
OPRM1 P35372 4/20 0.43
OPRD1 P41143 3/20 0.43
OPRK1 P41145 3/20 0.43
SLC22A1 O15245 1/20 0.43
SLC6A4 P31645 1/20 0.43
ADRA1A P35348 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5768389 1.00 CYP3A4 (0.47) CYP3A4CYP2D6CYP2C9CYP2C19MEN1
SCHEMBL9230909 0.80 CYP3A4 (0.46) CYP3A4CYP2D6CYP2C9CYP2C19MEN1
SCHEMBL24094559 0.75 CYP3A4 (0.61) CYP3A4CYP2D6CYP2C9CYP2C19MEN1
SCHEMBL2817086 0.75 CYP2D6 (0.67) CYP3A4CYP2D6CYP2C9CYP2C19MEN1
SCHEMBL8881736 0.74 CASP3 (0.46) CYP3A4CYP2D6CYP2C9CYP2C19MEN1
SCHEMBL8296543 0.73 CYP3A4 (0.50) CYP3A4CYP2D6CYP2C9CYP2C19MEN1
SCHEMBL15374438 0.73 CYP3A4 (0.50) CYP3A4CYP2D6CYP2C9CYP2C19MEN1
SCHEMBL8882202 0.72 CASP3 (0.46) CYP3A4CYP2D6CYP2C9CYP2C19MEN1
SCHEMBL431539 0.72 CYP3A4 (0.56) CYP3A4CYP2D6CYP2C9CYP2C19MEN1
SCHEMBL9231209 0.71 CYP3A4 (0.41) CYP3A4CYP2D6CYP2C9CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1667994-A1 QUINOLONE ANTIBACTERIAL AGENTS Warner-Lambert Company LLC (US) 2006-06-14 EP disclosed
US-20050119231-A1 Quinolone antibacterial agents ELLSWORTH EDMUND L (US) 2005-06-02 US disclosed
US-20050107423-A1 Quinolone antibacterial agents ELLSWORTH EDMUND L (US) 2005-05-19 US disclosed
WO-2005026154-A1 QUINOLONE ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY LLC (US) 2005-03-24 WO disclosed
WO-2005026165-A1 QUINOLONE ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY LLC (US) 2005-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050119231-A1 Quinolone antibacterial agents NQO2, MRPL21, TOP1 CYP3A4 400/4885CYP2D6 69/4885CYP2C9 527/4885
US-20050107423-A1 Quinolone antibacterial agents NQO2, MRPL21, TOP1 CYP3A4 400/4885CYP2D6 69/4885CYP2C9 527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.